Mandate

Vinge advises XVIVO in connection with a directed share issue of MSEK 250

November 01, 2021 Capital Markets and Public M&A

Vinge has advised XVIVO Perfusion AB in connection with a directed new issue of shares to Swedish and international investors that contributed MSEK 250 to XVIVO.

The subscription price of SEK 335, which corresponded to the closing price on Nasdaq Stockholm, was determined through an accelerated book-building procedure arranged by Carnegie and Bryan, Garnier & Co. The proceeds will be used for the financing of XVIVO’s acquisition of Star Teams Inc. which was published on the same day as the directed share issue.

Vinge’s team primarily consisted of Anders StridEdin Agic and Anna Ståhlklo.

 

Related

Vinge advises Summit Partners on its $1 billion-plus investment in Keyfactor

Vinge has, together with Kirkland & Ellis, advised Summit Partners in connection with a strategic growth investment in Keyfactor, a leader in trust infrastructure. The investment will help accelerate the company's global scale and growth initiatives, enabling product innovation, geographic expansion, team building and strategic acquisitions.
July 20, 2026

Vinge has advised VAROPreem in connection with its acquisition of Sunpine

Vinge has advised VAROPreem in connection with its acquisition of Sunpine from Sveaskog, Södra Skogsägarna and Lawter.
July 10, 2026

Vinge advises Consolid Equity in connection with the establishment of Petra Group

Vinge has advised Consolid Equity Investment AB ("Consolid Equity") on the acquisition of Ström & Gulliksson, one of the leading patent agencies in the Nordics. The acquisition forms part of the establishment of Petra Group, a European platform aimed at consolidating patent agencies across Europe to combine expertise and resources primarily within patents and trademarks. Consolid acts as a strategic partner in the new group.
July 08, 2026